Retifanlimab in patients with recurrent microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) endometrial cancer: Final results from the POD1UM-101 study (Cohort H)

被引：0
|
作者：
Berton-Rigaud, D. [1 ,2 ]
Pautier, P. [3 ,4 ]
Lorusso, D. [5 ,6 ]
Gennigens, C. [7 ]
Gladieff, L. [8 ,9 ]
Kryzhanivska, A. [10 ]
Bowman, J. [11 ]
Tian, C. [12 ]
Cornfeld, M.
Van Gorp, T. [13 ]
机构：
[1] GINECO, Serv Oncol Med, St Herblain, France
[2] Inst Cancerol IOuest ICO, St Herblain, France
[3] GINECO, Dept Med, Villejuif, France
[4] Inst Gustave Roussy, Villejuif, France
[5] Fdn Policlin Univ Agostino Gemelli, Gynecol Oncol Unit, Rome, Italy
[6] Univ Cattolica Sacro Cuore, Rome, Italy
[7] Ctr Hosp Univ Sart Tilman, Oncol Gynecol Unit, Liege, Belgium
[8] GINECO, Med Oncol Dept, Toulouse, France
[9] Inst Claudius Regaud IUCT Oncopole, Toulouse, France
[10] Ivano Frankivsk Natl Med Univ, Gynecol Surg Dept, Ivano Frankivsk, Ukraine
[11] Incyte Corp, Immuno Oncol, Wilmington, DE USA
[12] Incyte Corp, Biostat, Wilmington, DE USA
[13] Univ Hosp Leuven, Leuven Canc Inst, Dept Gynaecol, Div Gynaecol Oncol, Leuven, Belgium
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
755P
引用
收藏
页码：S517 / S517
页数：1
相关论文
共 50 条
  • [21] STRUCTURED LITERATURE REVIEW OF THE PREVALENCE OF MICROSATELLITE INSTABILITY HIGH (MSI-H) AND DEFICIENT MISMATCH REPAIR (DMMR) AMONG SOLID TUMORS
    Lorenzi, M.
    Amonkar, M.
    Zhang, J.
    Mehta, S.
    Liaw, K.
    VALUE IN HEALTH, 2018, 21 : S22 - S23
  • [22] Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET - a phase I, single-arm study
    Oaknin, Ana
    Gilbert, Lucy
    Tinker, Anna, V
    Brown, Jubilee
    Mathews, Cara
    Press, Joshua
    Sabatier, Renaud
    O'Malley, David M.
    Samouelian, Vanessa
    Boni, Valentina
    Duska, Linda
    Ghamande, Sharad
    Ghatage, Prafull
    Kristeleit, Rebecca
    Leath, Charles, III
    Guo, Wei
    Im, Ellie
    Zildjian, Sybil
    Han, Xinwei
    Duan, Tao
    Veneris, Jennifer
    Pothuri, Bhavana
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [23] Pembrolizumab in microsatellite instability-high (MSI-H)/mismatch repair deficient (dMMR) advanced solid tumors: An update of the phase II KEYNOTE-158 trial
    Maio, M.
    Ascierto, P. A.
    Motola Kuba, D.
    Penel, N.
    Cassier, P. A.
    Bariani, G. M.
    De Jesus-Acosta, A.
    Doi, T.
    Longo Munoz, F.
    Miller, W. H.
    Oh, D-Y.
    Gottfried, M.
    Yao, L.
    Jin, F. J.
    Gozman, A.
    Marabelle, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S589 - S590
  • [24] Neoadjuvant nivolumab plus ipilimumab in microsatellite instability-high (MSI-H)/deficient mismatch repair (dMMR) rectal tumors: ECOG-ACRIN EA2201
    Ciombor, K. K.
    Hong, S.
    Eng, C.
    Yao, X.
    You, N.
    Das, P.
    Chakravarthy, A.
    O'Dwyer, P. J.
    ANNALS OF ONCOLOGY, 2024, 35 : S104 - S104
  • [25] Nivolumab plus ipilimumab combination in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): First report of the full cohort from CheckMate-142.
    Andre, Thierry
    Lonardi, Sara
    Wong, Mark
    Lenz, Heinz-Josef
    Gelsomino, Fabio
    Aglietta, Massimo
    Morse, Michael
    Van Cutsem, Eric
    McDermott, Raymond S.
    Hill, Andrew G.
    Sawyer, Michael B.
    Hendlisz, Alain
    Neyns, Bart
    Svrcek, Magali
    Moss, Rebecca Anne
    Ledeine, Jean-Marie
    Cao, Z. Alexander
    Kamble, Shital
    Kopetz, Scott
    Overman, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [26] An unusual case of microsatellite instability-high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing
    Han, Bogyeong
    Kim, Sehui
    Koh, Jiwon
    Bae, Jeong Mo
    Yun, Hongseok
    Jeon, Yoon Kyung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2022, 56 (02) : 92 - 96
  • [27] Systematic literature review (SLR) of prognostic factors (PFs) in locally advanced rectal cancer (LARC) and mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) rectal cancer (RC).
    Capdevila, Jaume
    O'Donnell, Sean
    Borkowska, Katarzyna
    Frampton, James
    Betts, Marissa
    Maierhofer, Courtney
    Kalilani, Linda
    Garside, Jamie
    Wang, Huifen
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 303 - 303
  • [28] Neoadjuvant Immunotherapy Effectiveness in Patients With Microsatellite Instability-High (MSI-H) Gastric Cancer
    Chubenko, Viacheslav A.
    Navmatulya, Alexander Y.
    Gerk, Ivan A.
    Sarmatov, Artem A.
    V. Egorenkov, Vitaliy
    Shelekhova, Ksenia A.
    Zykov, Evgeny N.
    V. Chernobrivceva, Vera
    Volkov, Nikita M.
    Moiseyenko, Vladimir M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [29] Interim analysis of the immune-related endpoints of the mismatch repair deficient/microsatellite instability high (dMMR/MSI-H) and proficient/stable (MMRp/MSS) endometrial cancer cohorts from the GARNET study
    Hanker, L.
    Oaknin, A.
    Gilbert, L.
    Tinker, A., V
    Sabatier, R.
    Boni, V
    O'Malley, D.
    Ghamande, S.
    Duska, L.
    Ghatage, P.
    Sullivan, R. J.
    Moreno, V
    Veneris, J.
    Duan, T.
    Im, E.
    Pothuri, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 239 - 240
  • [30] Pembrolizumab in microsatellite instability high (MSI-H)/ mismatch repair deficient (dMMR) cancers: Updated analysis from phase 2 KEYNOTE-158 study.
    Maio, Michele
    Ascierto, Paolo Antonio
    Manzyuk, Ludmila
    Motola-Kuba, Daniel
    Penel, Nicolas
    Cassier, Philippe A.
    Bariani, Giovanni
    De Jesus-Acosta, Ana
    Doi, Toshihiko
    Longo, Federico
    Miller, Wilson H.
    Oh, Do-Youn
    Gottfried, Maya
    Wang, Ruixue
    Jin, Fan
    Norwood, Kevin Glen
    Marabelle, Aurelien
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345